The massively popular and successful Optrafair Birmingham, will be returning in 2016 from the 9th to 11th of April. The organisers of the event, the Federation of Manufacturing Opticians, have confirmed the optometric show will take take at the National Exhibition Centre across the three day period.
We all take for granted the photographs we take on a daily basis. We also take for granted 'red eye' which can appear in peoples eyes when a flash is used. But what would your reaction be if you saw a white glow in somebodies eye?
According to a new research project in the United States, close contact with cats and cockroaches can significantly increase your risk of glaucoma. Conversely, the same study showed a correlation between dogs and a decreased risk of the eye condition.
'Online Today', a new UK scheme designed to help the visually and hearing impaired use the internet, has been launched by the Royal National Institute of Blind People.
Pencil it in your diaries, National Eye Health Week 2015 is scheduled for the 21st to the 27th of September 2015. The UK's biggest eye health and vision campaign will cover a range of topics and themes across the seven day period, with a new subject on every 24 hours.
In order to help offer a better web experience for those who suffer with color/colour blindness (depending on your side of the Atlantic), Google and more specifically their Accessibility division have launched a plugin for their Chrome browser called Color Enhancer.
The Data Repository Project from the Local Optical Committee Support Unit is being launched to enable a better storage and research facility. Its primary goal is to allow researchers to gain a quicker grasp of public data than the current OptoManager system allows.
Sight Care 2015 is kicking off, for its sixth consecutive year, and is focusing on raising awareness amongst the public regarding independent eye care practices. Covering a wide range of media platforms, the group plans to continue its work in promoting the importance of regular eye testing.
The British Medical Journal, or BMJ, has launched a scathing attack on the use of the drug Lucentis in the treatment of age related macular degeneration, claiming that its use costs over £100m per year more than Avastin, which it believes could also be used for the condition.
Following alarming statistics regarding the percentage of children and young adults who have developed myopia, researchers are being prompted to delve deeper into the condition to investigate correlations that may indicate why so many young people are becoming affected by it.